Benzinga's Volume Movers
February 25, 2014 at 10:27 AM EST
InterMune (NASDAQ: ITMN ) shares moved up 126.43% to $31.61. The volume of InterMune shares traded was 4639%higher than normal. InterMune announced Phase 3 ASCEND trial results of pirfenidone in idiopathic pulmonary fibrosis. zulily (NASDAQ: ZU ) shares rose 43.46% to $61.46. The volume of zulily shares traded was
